P
P Vavassis
Publications - 7
Citations - 308
P Vavassis is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 149 citations.
Papers
More filters
Journal ArticleDOI
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Douglas Brand,Douglas Brand,Alison Tree,Alison Tree,Peter Ostler,Hans van der Voet,Andrew Loblaw,William Chu,Daniel Ford,Shaun Tolan,Suneil Jain,Alexander G.R. Martin,John Staffurth,Philip Camilleri,Kiran Kancherla,John Frew,Andrew K Chan,Ian S. Dayes,Daniel Henderson,Stephanie Brown,Clare Cruickshank,Stephanie Burnett,A. Duffton,Clare Griffin,Victoria Hinder,Kirsty Morrison,Kirsty Morrison,O. Naismith,Emma Hall,Nicholas van As,Nicholas van As,D Dodds,E Lartigau,S Patton,Alan J. Thompson,Mathias Winkler,P Wells,T Lymberiou,Daniel Saunders,M Vilarino-Varela,P Vavassis,Theodoros Tsakiridis,R Carlson,George Rodrigues,Jacob Tanguay,S Iqbal,Scott C. Morgan,A Mihai,A Li,O Din,Miguel Panades,R Wade,Yvonne Rimmer,J Armstrong,N Oommen +54 more
TL;DR: The results suggest that substantially shortening treatment courses with stereotactic body radiotherapy does not increase either gastrointestinal or genitourinary acute toxicity.
Journal ArticleDOI
Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer
Abdenour Nabid,Nathalie Carrier,Eric Vigneault,M. Brassard,Boris Bahoric,Robert Archambault,P Vavassis,F Vincent,Redouane Bettahar,Derek Wilke,T.V. Nguyen,Jean-Paul Bahary,Marie Duclos,Sylvie Vass,Luis Souhami +14 more
TL;DR: In this article , the clinical information on those patients labelled by investigators as dying from cardiovascular disease (CVD) aiming to confirm and precisely define the cause/diagnosis of their cardiovascular death.
Journal ArticleDOI
25: Oncologic Outcome, Toxicity and Cosmesis After Single-Fraction Neoadjuvant Radiotherapy for Low-Risk Breast Cancer
Danny Lavigne,David Tiberi,P Vavassis,David Nguyen,Marie-Christine Guilbert,Alexis S. Cloutier,Pierre Dubé,Mai-Kim Gervais,Lucas Sideris,Guy Leblanc,M P Dufresne,Tarek Hijal,M. İlker Yassa +12 more
Journal ArticleDOI
Testosterone recovery in patients with prostate cancer treated with radiotherapy and different ADT duration: Long-term data from two randomized trials.
Abdenour Nabid,Nathalie Carrier,Andre-Guy Martin,Eric Vigneault,François Vincent,M. Brassard,Boris Bahoric,Jean-Paul Bahary,Robert Archambault,Marie Duclos,P Vavassis,Redouane Bettahar,Thu Van Nguyen-Huynh,Derek Wilke,Luis Souhami +14 more
TL;DR: In this article , a multivariable logistic regression model was used to predict the probability of recovering normal T at baseline, including normal/abnormal T, age, Zubrod, comorbidities and ADT duration.
Journal ArticleDOI
109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials
Abdenour Nabid,Nathalie Carrier,Eric Vigneault,P Vavassis,M. Brassard,Boris Bahoric,Robert Archambault,François Vincent,Redouane Bettahar,Derek Wilke,Thu Van Nguyen,Andre-Guy Martin,Jean-Paul Bahary,Marie Duclos,Sylvie Vass,Luis Souhami +15 more